Sabato 27 ottobre 2012 - Pacini Editore
Sabato 27 ottobre 2012 - Pacini Editore
Sabato 27 ottobre 2012 - Pacini Editore
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
COmuNiCaziONi ORali<br />
microarray analysis in bone metastases from breast cancer (BrCa)<br />
patients who developed secondary lesions also in visceral organs<br />
or with metastases restricted to bone. Patients with metastases<br />
restricted to bone showed a longer overall survival compared to<br />
patients who rapidly developed multiple metastases involving<br />
also visceral organs. Our bioinformatic elaboration unveiled a<br />
cluster of genes that segregated the two groups. Among them, a<br />
set of genes was involved in oxygen binding and transport. We<br />
focused on β hemoglobin (HBB) that was not, so far, associated<br />
with the metastatic phenotype of BrCa. Based on this observation,<br />
we hypothesized a role of HBB in tumor progression 1.<br />
Therefore, the aim of the present study was to investigate HBB<br />
expression in primary human breast carcinoma and lymph node<br />
metastases, in order to investigate a potential correlation between<br />
such expression and known prognostic factors.<br />
Material and methods. Samples from 36 consecutive and<br />
unselected patients undergone surgery for breast cancer were<br />
included in this prospective study. A total of 38 primary lesions<br />
and 4 lymph node metastases from the same patients were investigated.<br />
3 cases of fibroadenoma and 1 case of papilloma were also<br />
included in the study. Histological sections were deparaffinized,<br />
incubated with 0.07M citrate buffer (pH 6), 15 min at 98° C, for<br />
antigen retrieval, treated with 3% H 2O 2 and incubated overnight<br />
at +4°C with the anti-HBB mouse monoclonal antibody (clone<br />
sc-21757, Santa Cruz Biotechnology Inc., Heidelberg, Germany).<br />
The staining signals were revealed using the Dako LSAB+ System-HRP.<br />
Slides were counterstained with Mayer’s hematoxylin.<br />
Red blood cells were used as internal positive control and negative<br />
controls were performed in parallel, by omitting primary antibody<br />
for each case. HBB expression in carcinoma was recorded<br />
as percentage of positively stained cells and correlated to known<br />
prognostic factors, namely histologic type, grading, estrogen<br />
(ER) and progesterone (PR) receptor expression, Ki-67 proliferation<br />
index and HER-2 score.<br />
Results. Positive staining was noted in our internal positive<br />
controls, red blood cells, and in endothelial cells. Multifocal<br />
immunostaining of extracellular space was noted in 8 cases and<br />
possibly related to hemoglobin diffusion in the interstitial compartment.<br />
Strong cytoplasmic positivity was noted in primary<br />
invasive carcinoma in 22 cases, mainly in scattered elements<br />
rESPIrATOrIO<br />
EML4-ALK rearrangements detection by FISH and<br />
rT-PCr in Formalin Fixed and Paraffin Embebbed<br />
tissues of non Small Cell Lung Cancer.<br />
N. Borrelli1 , R. Giannini1 , G. Alì2 , S. Pelliccioni2 , C. Niccoli2 ,<br />
G. Fontanini1,2 1 2 Department of Surgery, University of Pisa, Pisa; Unit of Pathologic<br />
Anatomy, Azienda Ospedaliera Universitaria Pisana, Pisa<br />
Introduction. A transforming fusion gene joining the echinoderm<br />
microtubule-associated protein-like 4 gene (EML4) and the<br />
anaplastic lymphoma kinase gene (ALK) has recently been found<br />
in a subset of non-small cell lung cancer (NSCLC). ALK encodes<br />
a receptor tyrosine kinase, which belongs to the insulin receptor<br />
superfamily. This protein comprises an extracellular domain, an<br />
hydrophobic stretch corresponding to a single pass transmem-<br />
<strong>Sabato</strong>, <strong>27</strong> <strong>ottobre</strong> <strong>2012</strong><br />
Sala Donatello – ore 8,30-10,30<br />
339<br />
or groups of cells. Percentage of positive cells ranged from 1 to<br />
45%. Cases with more than 10% positive cells were arbitrarily<br />
considered positive, accounting for 12 primary tumors. Two of<br />
four nodal metastases expressed HBB in a higher percentage<br />
than the primary tumor and one had the same percentage of the<br />
primary tumor. Primary tumors positive for HBB were 9 poorly<br />
differentiated (G3) infiltrating ductal carcinomas, 1 moderately<br />
differentiated (G2) ductal carcinoma and 2 infiltrating lobular<br />
carcinoma. The average age of the patients was 65.1 (range: 38-<br />
83). All but one expressed significant levels of hormone receptors,<br />
with an average proliferation index of 20 (range: 10-35) and<br />
all but two did not overexpress HER-2. The percentage of HBB<br />
positive cells was higher in the invasive lesions when compared<br />
with the coexisting in situ lesions in the 87% of the cases. Benign<br />
lesions tested, such as fibroadenoma and papilloma, as well as<br />
adenosis, papillomatosis and normal tissue observed outside the<br />
main tumor nodule, were all negative.<br />
Conclusions. Significant positivity of HBB was detected in primary<br />
BrCa tissue but not in normal breast epithelial cells and benign lesions,<br />
such as fibroadenoma, papilloma and adenosis, indicating that<br />
HBB expression is associated with the malignant cell phenotype.<br />
Infiltrating lesions showed higher percentage of HBB positive cells<br />
than in situ counterparts, as well as greater values of positivity were<br />
found in lymph node metastases, compared to the corresponding<br />
primary tumors. The majority of the HBB positive tumors were high<br />
grade ductal carcinoma with moderately high proliferation index,<br />
significant levels of hormone receptors and without HER2 overexpression.<br />
These findings suggest that HBB expression by neoplastic<br />
cells may identify a subgroup of lesions with a more aggressive<br />
potential. Even though follow-up data and further investigation are<br />
needed to clarify the prognostic value and the statistical significance<br />
of HBB expression in primary breast cancers, our results suggest a<br />
possible positive correlation between HBB expression and tumor<br />
cell aggressiveness, paving the way for a possible use of HBB as a<br />
novel marker for breast cancer characterization.<br />
references<br />
1 Capulli M, Angelucci A, Driouch K, et al. Increased expression of a<br />
set of genes enriched in oxygen binding function discloses a predisposition<br />
of breast cancer bone metastases to generate metastasis spread<br />
in multiple organs. J Bone Mineral Research <strong>2012</strong>; in press.<br />
brane region, and an intracellular kinase domain. It plays an<br />
important role in the cell proliferation, survival migration, and<br />
alteration in cytoskeletal rearrangement 1 . EML4 is a cytoplasmic<br />
protein that is a human homolog of echinoderm microtubule<br />
associated protein, the major microtubule binding protein in<br />
dividing sea urchin eggs, and is essential for the formation of<br />
microtubules 1 . It is composed of a N-terminal basic region, a<br />
HELP domain and four WD repeats in the C-terminus. EML4<br />
and ALK are situated on the short arm of chromosome 2 (2p21<br />
and 2p23, respectively) where they are separated by a distance<br />
of 12.2 megabases and are oriented in opposite directions 2 . The<br />
small inversion within chromosome 2p leads to the EML4-ALK<br />
fusion gene. Multiple EML4-ALK variants have been identified<br />
since EML4 truncation does not always occur in the same location<br />
(at exons 2, 6, 13, 14, 15, 18 or 20); the intracellular tyrosine<br />
kinase domain of ALK (encoded by exon 20) is conserved among<br />
the variants. The most common variants were E13;A20 (the<br />
nomenclature refers to the exons in EML4 (E) that are fused to